MARKET

SERA

SERA

Sera Prognostics, Inc.
NASDAQ
3.790
-0.140
-3.56%
After Hours: 3.790 0 0.00% 16:45 03/21 EDT
OPEN
3.930
PREV CLOSE
3.930
HIGH
4.020
LOW
3.770
VOLUME
350.78K
TURNOVER
--
52 WEEK HIGH
12.36
52 WEEK LOW
3.770
MARKET CAP
142.74M
P/E (TTM)
-3.8210
1D
5D
1M
3M
1Y
5Y
1D
Sera Prognostics Earnings Call: Balancing Success and Challenges
TipRanks · 1d ago
Sera Prognostics, Inc. (SERA) Reports Q4 Loss, Misses Revenue Estimates
NASDAQ · 3d ago
Sera Prognostics GAAP EPS of -$0.25 misses by $0.01, revenue of $0.02M
Seeking Alpha · 3d ago
SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF JEFF ELLIOTT TO ITS BOARD; RYAN TRIMBLE AND MARCUS WILSON TO STEP DOWN
Reuters · 3d ago
Sera Prognostics Q4 2024 GAAP EPS $(0.25) Misses $(0.24) Estimate, Sales $24.000K Beat $15.000K Estimate
Benzinga · 3d ago
*Sera Prognostics 4Q Loss/Shr 25c >SERA
Dow Jones · 3d ago
*Sera Prognostics 4Q Rev $24,000 >SERA
Dow Jones · 3d ago
SERA PROGNOSTICS Q4 OPERATING EXPENSES USD 9.447 MILLION
Reuters · 3d ago
More
About SERA
Sera Prognostics, Inc. is a women's health diagnostic company utilizing its proprietary proteomics and bioinformatics platform, and significant data resources to enhance maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. It has built a proteomics and bioinformatics platform to characterize the biology of pregnancy and to discover and validate key protein biomarkers found in blood that are accurate predictors of dynamic changes that occur during pregnancy. Its commercial product, the PreTRM test, is a validated, commercially available blood-based biomarker test to predict the risk of a premature delivery, also known as preterm birth. The PreTRM test is a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation that provides a prediction of the expectant mother’s risk of delivering spontaneously before 37 weeks’ gestation.

Webull offers Sera Prognostics Inc stock information, including NASDAQ: SERA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SERA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SERA stock methods without spending real money on the virtual paper trading platform.